Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CA4 | P22748 | 4/20 | 0.44 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL10839221 | 0.92 | CA1 (0.61) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL6844517 | 0.92 | CA1 (0.61) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL31657790 | 0.92 | CA1 (0.61) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL10838736 | 0.92 | CA1 (0.61) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL1039724 | 0.92 | CA1 (0.69) | CA1LMNACA4SLC34A1CA5A | |
| Phosphoric Acid SCHEMBL5509352 | 0.89 | CA1 (0.57) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL17978035 | 0.89 | CA1 (0.57) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL2362456 | 0.89 | CA1 (0.64) | CA1LMNACA4SLC34A1CA5A | |
| Phosphoric Acid SCHEMBL5806288 | 0.89 | CA1 (0.57) | CA1LMNACA4SLC34A1TSHR | |
| Phosphoric Acid SCHEMBL31536919 | 0.89 | CA1 (0.64) | CA1LMNACA4SLC34A1CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3256105-B1 | METHOD OF PRODUCING A GRANULATED COMPOSITION | CUBIC PHARMACEUTICALS LTD (GB) | 2023-11-01 | — | — | EP | disclosed |
| US-11246833-B2 | Method of producing a granulated composition | CUBIC PHARMACEUTICALS LTD. (GB) | 2022-02-15 | — | — | US | disclosed |
| US-20180015040-A1 | METHOD OF PRODUCING A GRANULATED COMPOSITION | CUBIC PHARMACEUTICALS LTD. (GB) | 2018-01-18 | — | — | US | disclosed |
| EP-3256105-A1 | METHOD OF PRODUCING A GRANULATED COMPOSITION | Cubic Pharmaceuticals Ltd. (GB) | 2017-12-20 | — | — | EP | disclosed |
| WO-2016128726-A1 | METHOD OF PRODUCING A GRANULATED COMPOSITION | CUBIC PHARMACEUTICALS LTD. (GB) | 2016-08-18 | — | — | WO | disclosed |